CD1D and myeloid sarcoma: However, there was an increase (p=0.042) in the number of CD19+CD27−IgD+CD5+CD1d+ naïve Bregs in MS, 4.6 ± 0.9 cells/μL compared to HC, 2.3 ± 0.7 cells/μL (Figure 2E).